These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29032944)

  • 1. [Observational study of outpatient unit duration of stay depending on the route of administration (intravenous vs subcutaneous) for a targeted therapy].
    Despiau F; Zagala Y; Delord JP; Montastruc M; Lacaze JL; Ferrand R; Bombail M
    Bull Cancer; 2017 Oct; 104(10):869-874. PubMed ID: 29032944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)].
    Favier M; Le Goc-Sager F; Vincent-Cantini I; Launay V; Giroux EA; Lièvremont K; Bonnet I; Barbe C; Duval E; Loric N; Delbaldo C
    Bull Cancer; 2018 Oct; 105(10):862-872. PubMed ID: 30244982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implementation of a remote oncology-monitoring program for cancer patients in outpatient care unit: A major challenge for the different actors].
    Peyrilles E; Lepage-Seydoux C; Sejean K; Bonan B
    Bull Cancer; 2018 Apr; 105(4):357-367. PubMed ID: 29499998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Supportive day care at a cancer center: A comparative study of 2008 versus 2016 activity].
    Bimboes A; Frasie V; Thiery A
    Bull Cancer; 2020 Feb; 107(2):181-190. PubMed ID: 32005357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intravenous Versus Subcutaneous Phytonadione on Length of Stay for Patients in Need of Urgent Warfarin Reversal.
    Mottice BL; Soric MM; Legros E
    Am J Ther; 2016; 23(2):e345-9. PubMed ID: 25461960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study.
    Fahimi F; Ariapanah P; Faizi M; Shafaghi B; Namdar R; Ardakani MT
    Aust Crit Care; 2008 May; 21(2):110-6. PubMed ID: 18387813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous versus intravenous bortezomib: efficiency practice variables and patient preferences.
    Barbee MS; Harvey RD; Lonial S; Kaufman JL; Wilson NM; McKibbin T; Hutcherson DA; Surati M; Valla K; Shah KS
    Ann Pharmacother; 2013 Sep; 47(9):1136-42. PubMed ID: 24259728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and Outpatients.
    Gross I; Trentino KM; Andreescu A; Pierson R; Maietta RA; Farmer S
    Oncologist; 2016 Mar; 21(3):327-32. PubMed ID: 26865590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries.
    De Cock E; Kritikou P; Sandoval M; Tao S; Wiesner C; Carella AM; Ngoh C; Waterboer T
    PLoS One; 2016; 11(6):e0157957. PubMed ID: 27362533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a model of outpatient chemotherapy delivery--chemotherapy basic treatment equivalent (CBTE).
    Delaney G; Jalaludin B; Moylan E; Barton M
    Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):406-12. PubMed ID: 12555880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administrative outcomes five years after opening an acute palliative care unit at a comprehensive cancer center.
    Bryson J; Coe G; Swami N; Murphy-Kane P; Seccareccia D; Le LW; Rodin G; Zimmermann C
    J Palliat Med; 2010 May; 13(5):559-65. PubMed ID: 20192842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site.
    Ng P; Incekol D; Lee R; Paisley E; Dara C; Brandle I; Kaufman M; Chen C; Trudel S; Tiedemann R; Reece D; Kukreti V
    J Oncol Pharm Pract; 2015 Aug; 21(4):285-92. PubMed ID: 24781451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
    Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
    J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between intravenous recombinant human erythropoietin and subcutaneous injection in Thai hemodialysis patients.
    Trakarnvanich T; Thitiarcharkul S
    J Med Assoc Thai; 2004 Sep; 87(9):1041-7. PubMed ID: 15516004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial.
    Merz M; Salwender H; Haenel M; Mai EK; Bertsch U; Kunz C; Hielscher T; Blau IW; Scheid C; Hose D; Seckinger A; Jauch A; Hillengass J; Raab MS; Schurich B; Munder M; Schmidt-Wolf IG; Gerecke C; Lindemann HW; Zeis M; Weisel K; Duerig J; Goldschmidt H
    Haematologica; 2015 Jul; 100(7):964-9. PubMed ID: 25840597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of waiting time and length of stay between 2005 and 2012 in an obstetric and gynaecologic emergency unit in a French teaching hospital].
    Coutin AS; Vaucel E
    J Gynecol Obstet Biol Reprod (Paris); 2014 May; 43(5):371-8. PubMed ID: 24120295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term care and day care in Bitterfeld].
    Kaluza J
    Pflege Aktuell; 1997 Oct; 51(10):590-4. PubMed ID: 9456784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.